---
title: "Acute Coronary Syndrome Clinical Trials — Patient Guide | Amavita Research"
url: https://md.amavitaresearch.com/blog/acute-coronary-syndrome-clinical-trials-patient-guide
canonical: https://www.amavitaresearch.com/blog/acute-coronary-syndrome-clinical-trials-patient-guide
schema_type: Article
last_updated: 2026-05-13
---

# Acute Coronary Syndrome Clinical Trials — Patient Guide

Acute coronary syndrome (ACS) covers heart attack (myocardial infarction, MI) and unstable angina. If you've had an ACS event, clinical trials may be available that study how to reduce the risk of a second event.

## What ACS clinical trials test

- New anticoagulants and antiplatelet medications
- Lipid-lowering therapies (PCSK9 inhibitors, lipoprotein(a) targeting agents)
- Anti-inflammatory therapies
- Post-PCI optimization strategies
- Long-term cardiovascular outcomes

## Trial currently enrolling at Amavita Research

- **LIBREXIA-ACS (Pfizer)** — C4921003, Phase 3 acute coronary syndrome. https://www.amavitaresearch.com/trials/librexia-acs

## Who typically qualifies

- Recent acute coronary syndrome event (within a defined window from the index event)
- Successful PCI (if applicable to the protocol)
- Stable enough for outpatient enrollment
- On stable cardiovascular medications (specific medication requirements vary)
- Adult (specific age range varies by trial)

## What patients can expect

- Free trial-related care — study drug, study procedures, study tests
- Bilingual coordinators (English / Spanish / Haitian Creole / Portuguese)
- Co-management with your interventional cardiologist and primary care physician
- Follow-up visits at protocol-defined intervals (typically monthly or quarterly)
- Same-day troponin, hs-CRP, lipid panel processing on-site
- Possibility of additional cath-lab procedures if protocol requires
- 24/7 contact number for trial-related questions

## How enrollment typically happens after an ACS event

1. After discharge from the hospital, your interventional cardiologist or PCP may suggest a trial
2. Call (786) 703-5941 or email research@amavita.health
3. Coordinator does a brief screening call to confirm timing fits the trial's enrollment window
4. Screening visit at the site
5. PI reviews and confirms eligibility
6. Informed consent — take it home, read it, ask questions, decide

Many ACS trials have a tight post-event enrollment window (days to weeks), so prompt outreach matters. You can withdraw at any time, for any reason.

## Key links

- Therapeutic area: https://www.amavitaresearch.com/therapeutic-areas/acute-coronary-syndrome
- LIBREXIA-ACS trial detail: https://www.amavitaresearch.com/trials/librexia-acs
- Patient FAQ: https://www.amavitaresearch.com/faq-patients
- What to expect: https://www.amavitaresearch.com/blog/what-to-expect-cardiovascular-clinical-trial
- Contact: https://www.amavitaresearch.com/contact-patient · (786) 703-5941